Aligos Therapeutics and Metrion explore key approaches to cardiovascular safety screening in drug discovery.
Studying ion channels on the lysosomal membrane is essential for understanding lysosomal function, cellular homeostasis, and the development of various neurological diseases, such as Parkinson's disease. This research has the potential to uncover new therapeutic targets and improve our knowledge of fundamental cellular processes.
In this video we demonstrate how to perform the lysosomal patch clamp technique to study ion channels on the lysosomal membrane.
Aligos Therapeutics and Metrion explore key approaches to cardiovascular safety screening in drug discovery.
Academic case study on Nav1.9 as a drug target by Associate Professor David Bulmer (University of Cambridge). Overview of Metrion’s newly developed Nav1.9 screening assays by Metrion CSO, Dr. Eddy Stevens.